Medicalgorithmics S.A. (MDG.WA)
PLN 24.75
(3.99%)
PLN 24.75
(3.99%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -19.81 Million PLN | 24.25% |
| 2022 | -26.15 Million PLN | -1191.65% |
| 2021 | -2.02 Million PLN | -108.73% |
| 2020 | 23.18 Million PLN | -20.5% |
| 2019 | 29.16 Million PLN | 384.74% |
| 2018 | 6.01 Million PLN | -77.01% |
| 2017 | 26.16 Million PLN | 905.65% |
| 2016 | 2.6 Million PLN | 113.05% |
| 2015 | -19.93 Million PLN | 17.63% |
| 2014 | -24.19 Million PLN | 36.94% |
| 2013 | -38.37 Million PLN | 34.35% |
| 2012 | -58.45 Million PLN | 0.0% |
| 2011 | - PLN | 0.0% |
| 2010 | - PLN | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -9.59 Million PLN | 13.24% |
| 2024 Q1 | -12.18 Million PLN | 38.48% |
| 2023 Q4 | -19.81 Million PLN | 16.05% |
| 2023 Q1 | -31.11 Million PLN | -18.96% |
| 2023 Q2 | -33.27 Million PLN | -6.95% |
| 2023 Q3 | -23.6 Million PLN | 29.07% |
| 2023 FY | -19.81 Million PLN | 24.25% |
| 2022 Q2 | 4.11 Million PLN | -50.93% |
| 2022 Q1 | 8.38 Million PLN | 513.83% |
| 2022 FY | -26.15 Million PLN | -1191.65% |
| 2022 Q4 | -26.15 Million PLN | -134.69% |
| 2022 Q3 | -11.14 Million PLN | -371.04% |
| 2021 Q3 | 10.58 Million PLN | 154.62% |
| 2021 Q4 | -2.02 Million PLN | -119.13% |
| 2021 Q2 | 4.15 Million PLN | -50.89% |
| 2021 FY | -2.02 Million PLN | -108.73% |
| 2021 Q1 | 8.46 Million PLN | -63.48% |
| 2020 Q1 | 33.83 Million PLN | 16.02% |
| 2020 Q2 | 8.99 Million PLN | -73.42% |
| 2020 Q3 | 14.38 Million PLN | 59.94% |
| 2020 Q4 | 23.18 Million PLN | 61.17% |
| 2020 FY | 23.18 Million PLN | -20.5% |
| 2019 FY | 29.16 Million PLN | 384.74% |
| 2019 Q4 | 29.16 Million PLN | 9.5% |
| 2019 Q1 | 28.27 Million PLN | 370.03% |
| 2019 Q3 | 26.63 Million PLN | -0.87% |
| 2019 Q2 | 26.86 Million PLN | -4.99% |
| 2018 Q1 | 38.57 Million PLN | 47.41% |
| 2018 FY | 6.01 Million PLN | -77.01% |
| 2018 Q4 | 6.01 Million PLN | -67.57% |
| 2018 Q3 | 18.55 Million PLN | -11.63% |
| 2018 Q2 | 20.99 Million PLN | -45.57% |
| 2017 FY | 26.16 Million PLN | 905.65% |
| 2017 Q3 | 43.53 Million PLN | -22.09% |
| 2017 Q2 | 55.88 Million PLN | -21.99% |
| 2017 Q1 | 71.63 Million PLN | 2653.0% |
| 2017 Q4 | 26.16 Million PLN | -39.9% |
| 2016 FY | 2.6 Million PLN | 113.05% |
| 2016 Q4 | 2.6 Million PLN | -95.22% |
| 2016 Q3 | 54.43 Million PLN | -3.75% |
| 2016 Q1 | 71.41 Million PLN | 458.32% |
| 2016 Q2 | 56.55 Million PLN | -20.81% |
| 2015 Q1 | -25.36 Million PLN | -4.83% |
| 2015 Q3 | -19.97 Million PLN | 49.33% |
| 2015 Q4 | -19.93 Million PLN | 0.24% |
| 2015 FY | -19.93 Million PLN | 17.63% |
| 2015 Q2 | -39.43 Million PLN | -55.45% |
| 2014 Q1 | -36.01 Million PLN | 6.15% |
| 2014 Q3 | -19.26 Million PLN | 24.11% |
| 2014 Q4 | -24.19 Million PLN | -25.64% |
| 2014 FY | -24.19 Million PLN | 36.94% |
| 2014 Q2 | -25.38 Million PLN | 29.53% |
| 2013 FY | -38.37 Million PLN | 34.35% |
| 2013 Q1 | -52.35 Million PLN | 10.43% |
| 2013 Q3 | -39.77 Million PLN | 11.19% |
| 2013 Q4 | -38.37 Million PLN | 3.53% |
| 2013 Q2 | -44.78 Million PLN | 14.44% |
| 2012 FY | -58.45 Million PLN | 0.0% |
| 2012 Q4 | -58.45 Million PLN | 0.0% |
| 2011 FY | - PLN | 0.0% |
| 2010 FY | - PLN | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Adiuvo Investments S.A. | 22.92 Million PLN | 186.44% |
| Genomtec S.A. | -2.2 Million PLN | -797.328% |
| Medinice S.A. | -9.81 Million PLN | -101.864% |
| Synektik Spólka Akcyjna | -43.8 Million PLN | 54.768% |